Oppenheimer Asset Management Inc. Purchases 2,464 Shares of Koninklijke Philips N.V. (NYSE:PHG)

Oppenheimer Asset Management Inc. increased its holdings in Koninklijke Philips N.V. (NYSE:PHG) by 1.5% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 164,789 shares of the technology company’s stock after buying an additional 2,464 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Koninklijke Philips were worth $4,186,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Sequoia Financial Advisors LLC raised its holdings in shares of Koninklijke Philips by 4.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 8,932 shares of the technology company’s stock valued at $226,000 after acquiring an additional 384 shares in the last quarter. Dorsey & Whitney Trust CO LLC increased its position in shares of Koninklijke Philips by 3.9% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 11,401 shares of the technology company’s stock worth $289,000 after purchasing an additional 427 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock valued at $54,000 after purchasing an additional 582 shares in the last quarter. Pzena Investment Management LLC lifted its position in Koninklijke Philips by 5.1% during the fourth quarter. Pzena Investment Management LLC now owns 13,683 shares of the technology company’s stock valued at $346,000 after purchasing an additional 670 shares during the last quarter. Finally, Atria Investments Inc grew its stake in Koninklijke Philips by 4.1% in the 4th quarter. Atria Investments Inc now owns 19,009 shares of the technology company’s stock worth $481,000 after buying an additional 741 shares in the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

NYSE:PHG opened at $23.91 on Thursday. The business has a 50 day moving average of $23.70 and a 200 day moving average of $25.08. The company has a market capitalization of $23.02 billion, a price-to-earnings ratio of 55.61, a PEG ratio of 0.68 and a beta of 0.76. Koninklijke Philips N.V. has a 1-year low of $20.61 and a 1-year high of $31.57. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.28 and a quick ratio of 0.79.

Koninklijke Philips (NYSE:PHG) last posted its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.14 by $0.13. Koninklijke Philips had a net margin of 2.11% and a return on equity of 10.97%. The firm had revenue of $4.31 billion for the quarter, compared to the consensus estimate of $4.10 billion. During the same period last year, the firm posted $0.21 earnings per share. The business’s revenue was down 1.0% compared to the same quarter last year. On average, sell-side analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Sunday, June 15th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 18th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.